Four new HIV-1 group N isolates from Cameroon: Prevalence continues to be low

A Vallari, P Bodelle, C Ngansop… - AIDS research and …, 2010 - liebertpub.com
A Vallari, P Bodelle, C Ngansop, F Makamche, N Ndembi, D Mbanya, L Kaptué, LG Gürtler…
AIDS research and human retroviruses, 2010liebertpub.com
Abstract Analysis of 3555 HIV-seropositive specimens, collected in Cameroon from 2002 to
2006, led to the identification of four HIV-1 group N infections based on differential
seroreactivity to HIV env-derived peptides and proteins and confirmation by nucleic acid
amplification. Group N prevalence continues to be low accounting for only 0.1% of HIV
infections in Cameroon. Near full-length genomic sequences were obtained from viral RNA
or proviral DNA by PCR amplification of overlapping fragments for three isolates, 06CM …
Abstract
Analysis of 3555 HIV-seropositive specimens, collected in Cameroon from 2002 to 2006, led to the identification of four HIV-1 group N infections based on differential seroreactivity to HIV env-derived peptides and proteins and confirmation by nucleic acid amplification. Group N prevalence continues to be low accounting for only 0.1% of HIV infections in Cameroon. Near full-length genomic sequences were obtained from viral RNA or proviral DNA by PCR amplification of overlapping fragments for three isolates, 06CM-U14296, 06CM-U14842, and 02CM-SJGddd. Two genome segments, partial pol and env–nef, were obtained from viral RNA for the fourth isolate, 02CM-TIM0217. With the four group N isolates identified in this study and group N sequences previously reported, eight near full-length and five partial genome sequences are now available. Despite genetic divergence from HIV-1 group M and O, all of the group N infections evaluated by five commercial HIV immunoassays were detected.
Mary Ann Liebert